Skip to main content

Rhodopsin transgenic pigs as a model for human retinitis pigmentosa.

Publication ,  Journal Article
Li, ZY; Wong, F; Chang, JH; Possin, DE; Hao, Y; Petters, RM; Milam, AH
Published in: Invest Ophthalmol Vis Sci
April 1998

PURPOSE: To further characterize the retinas of Pro3471Leu rhodopsin transgenic pigs, a model for human retinitis pigmentosa. METHODS: Retinas from normal and transgenic pigs, newborn to 20 months old, were processed for light and electron microscopic immunocytochemical examination. RESULTS: At birth, rod numbers were normal in the transgenic retinas, but their outer segments were short and disorganized and their inner segments contained stacks of rhodopsin-positive membranes. The newborn rod synapses lacked synaptic vesicles and ribbons and had numerous rhodopsin-positive, filopodia-like processes that extended past the cone synapses into the outer plexiform layer. Rod cell death was apparent by 2 weeks and was pronounced in the mid periphery and central regions by 6 weeks. Far peripheral rods were initially better preserved, but by 9 months virtually all rods had degenerated. Cones degenerated more slowly than rods, but by 4 weeks the cone synapses were shrunken and some mid peripheral cones had lost their immunoreactivity for phosphodiesterase-gamma, arrestin, and recoverin. From 9 months to 20 months, the cone outer segments shortened progressively, and more cones lost immunoreactivity for these proteins. CONCLUSIONS: The rhodopsin transgenic pig retina shares many cytologic features with human retinas with retinitis pigmentosa and provides an opportunity to examine the earliest stages in photoreceptor degeneration, about which little is known in humans. The finding of abnormal rhodopsin localization in newborn rods is consistent with misrouting of mutant rhodopsin as an early process leading to rod cell death. Novel changes in the photoreceptor synapses may correlate with early electrophysiological abnormalities in these retinas.

Duke Scholars

Published In

Invest Ophthalmol Vis Sci

ISSN

0146-0404

Publication Date

April 1998

Volume

39

Issue

5

Start / End Page

808 / 819

Location

United States

Related Subject Headings

  • Swine
  • Rhodopsin
  • Retinitis Pigmentosa
  • Retinal Pigments
  • Photoreceptor Cells
  • Ophthalmology & Optometry
  • Neuroglia
  • Fluorescent Antibody Technique, Indirect
  • Eye Proteins
  • Disease Models, Animal
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, Z. Y., Wong, F., Chang, J. H., Possin, D. E., Hao, Y., Petters, R. M., & Milam, A. H. (1998). Rhodopsin transgenic pigs as a model for human retinitis pigmentosa. Invest Ophthalmol Vis Sci, 39(5), 808–819.
Li, Z. Y., F. Wong, J. H. Chang, D. E. Possin, Y. Hao, R. M. Petters, and A. H. Milam. “Rhodopsin transgenic pigs as a model for human retinitis pigmentosa.Invest Ophthalmol Vis Sci 39, no. 5 (April 1998): 808–19.
Li ZY, Wong F, Chang JH, Possin DE, Hao Y, Petters RM, et al. Rhodopsin transgenic pigs as a model for human retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1998 Apr;39(5):808–19.
Li, Z. Y., et al. “Rhodopsin transgenic pigs as a model for human retinitis pigmentosa.Invest Ophthalmol Vis Sci, vol. 39, no. 5, Apr. 1998, pp. 808–19.
Li ZY, Wong F, Chang JH, Possin DE, Hao Y, Petters RM, Milam AH. Rhodopsin transgenic pigs as a model for human retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1998 Apr;39(5):808–819.

Published In

Invest Ophthalmol Vis Sci

ISSN

0146-0404

Publication Date

April 1998

Volume

39

Issue

5

Start / End Page

808 / 819

Location

United States

Related Subject Headings

  • Swine
  • Rhodopsin
  • Retinitis Pigmentosa
  • Retinal Pigments
  • Photoreceptor Cells
  • Ophthalmology & Optometry
  • Neuroglia
  • Fluorescent Antibody Technique, Indirect
  • Eye Proteins
  • Disease Models, Animal